Xiaodong Wang, Director at BeiGene, Ltd. (BGNE), sold 87,652 shares at $189.03 ($16.7M) on 2024-11-26, disclosed to the SEC on 2024-11-29.
Scheduled sale ($16.7M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $187.15 | 1,014 | $190K | 1.1% |
| 2 | $187.15 | 1,014 | $190K | 1.1% |
| 3 | $187.16 | 4,425 | $828K | 5.0% |
| 4 | $187.61 | 300 | $56K | 0.3% |
| 5 | $187.61 | 300 | $56K | 0.3% |
| 6 | $187.98 | 5,875 |
| $1.1M |
| 6.6% |
| 7 | $187.98 | 5,875 | $1.1M | 6.6% |
| 8 | $188.08 | 1,186 | $223K | 1.3% |
| 9 | $188.08 | 1,186 | $223K | 1.3% |
| 10 | $188.55 | 400 | $75K | 0.5% |
| 11 | $189.03 | 600 | $113K | 0.7% |
| 12 | $189.17 | 2,700 | $511K | 3.1% |
| 13 | $189.17 | 2,700 | $511K | 3.1% |
| 14 | $189.76 | 200 | $38K | 0.2% |
| 15 | $190.31 | 1,475 | $281K | 1.7% |
| 16 | $190.31 | 1,475 | $281K | 1.7% |
| 17 | $190.32 | 6,187 | $1.2M | 7.1% |
| 18 | $190.32 | 6,187 | $1.2M | 7.1% |
| 19 | $191.05 | 700 | $134K | 0.8% |
| 20 | $191.22 | 12,293 | $2.4M | 14.1% |
| 21 | $191.22 | 12,293 | $2.4M | 14.1% |
| 22 | $191.24 | 2,725 | $521K | 3.1% |
| 23 | $191.81 | 407 | $78K | 0.5% |
| 24 | $191.81 | 407 | $78K | 0.5% |
| 25 | $191.89 | 883 | $169K | 1.0% |
| 26 | $191.89 | 883 | $169K | 1.0% |
| 27 | $191.96 | 6,981 | $1.3M | 8.0% |
| 28 | $191.96 | 6,981 | $1.3M | 8.0% |
| Total | $190.20 avg | 87,652 | $16.7M | 100% |
| Filing → |
| ONC | SELL | 2025-06-25 | $668K | — | Filing → |
| ONC | SELL | 2025-06-12 | $21.9M | — | Filing → |
| BGNE | SELL | 2025-05-15 | $18.6M | — | Filing → |